HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cooperation experience in a multicentre study to define the upper limits in a normal population for the diagnostic assessment of the functional lupus anticoagulant assays.

AbstractBACKGROUND:
Phospholipid-dependent coagulation tests for lupus anticoagulant (LA) are considered an important step for the diagnosis of anti-phospholipid syndrome; however, LA laboratory detection is difficult because of many variables. Five hospital laboratories, located in a North-Italy area and using the same method for LA testing, cooperated to standardise sample treatment and analytical procedure in order to define the upper values for LA negativity.
METHODS:
In total, 200 normal subjects (40 for each centre) were studied for six LA functional assays, using the same procedure, reagent lot and analyser type. The first tests done were LA screen and LA confirm assays, based on diluted Russell's Viper Venom Time, with low and high phospholipid content, respectively. The second tests performed were silica clotting time screen and confirm assays, based on activated partial thromboplastin time, with low and high phospholipid content, respectively. Finally, two mixing assays were executed for both screening assays, diluting patient sample with a pool prepared with plasma collected from the study population.
RESULTS:
Data analysis demonstrated a difference between centres for all assays when results were expressed in seconds; the difference disappeared when results are normalised with the local mean normal value of each centre and are expressed as a normalised ratio. The study population was normally distributed; so the value corresponding to 99th percentile was used as limit value for LA negativity. Values expressed as normalised ratio, for LA and silica clotting time screenings were 1.22 and 1.23, respectively.
CONCLUSIONS:
The study allowed us to define a uniform approach to LA testing and evaluation for laboratories employing the same methods.
AuthorsPaola Pradella, Gabriella Azzarini, Liliana Santarossa, Livio Caberlotto, Cristina Bardin, Alessandra Poz, Federica D'Aurizio, Roberta Giacomello
JournalClinical chemistry and laboratory medicine (Clin Chem Lab Med) Vol. 51 Issue 2 Pg. 379-85 (Feb 2013) ISSN: 1437-4331 [Electronic] Germany
PMID23001319 (Publication Type: Journal Article, Multicenter Study)
Chemical References
  • Lupus Coagulation Inhibitor
Topics
  • Adolescent
  • Adult
  • Aged
  • Antiphospholipid Syndrome (blood, diagnosis, immunology)
  • Blood Coagulation Tests (standards)
  • Female
  • Humans
  • Lupus Coagulation Inhibitor (blood)
  • Male
  • Middle Aged
  • Multicenter Studies as Topic
  • Reference Values
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: